Antileukemic pyrone 1 was synthesized by way of a five-step procedure from 4- . This is the first synthesis of 4-methoxy-6-methyl-5-(3-oxobutyl)-2H-pyran-2-one (1).
In 2014 Ross and coworkers isolated the novel alpha-pyrones 1−3 from Alternaria phragmospora, an endophytic fungus from Vinca rosea leaves. Structures 1−3 are shown in Figure 1 . Compound 1 showed promising antileukemic activities against HL60 cells with IC 50 values of 0.9 μM and against K562 cells with IC 50 values of 1.5 μM [1] . Pyrone 1 bears a substituent at the C-5 position and no substituent at C-3. This is rare among pyrone natural products. Compound 4 was recently isolated from the endophytic fungus Embellisia sp [2] . Initially, our strategy was to transform commercially available keto pyrone 5 into bromopyrone 6 by way of the three-step pathway shown in Scheme 1 [3] . We then expected to utilize palladium mediated coupling reactions to produce either 1 or 7. Unfortunately, neither the Heck reaction with methyl vinyl ketone or 1-buten-3-ol nor the Sonogashira reaction with 3-butyn-2-ol afforded the desired products [4] [5] . Either returned starting material or debrominated products were recovered.
Presumably, the substituents at C-4 and C-6 were responsible, since 4-bromo-pyrone undergoes straightforward couplings [6]. In view of the unexpected recalcitrance of 6, we devised a new strategy shown in Scheme 2 focusing on pyrone 8, readily available in one step from ethyl acetoacetate and malonyl chloride [7] . Selective reduction of the ester in pyrone 8 was difficult. Fortunately, a report from Shimizu that borane-dimethyl sulfide complex selectively reduces esters in the presence of pyrones enabled the selective reduction of 8 in 96% yield [8] . Methylation using dimethyl sulfate provided pyrone 9 in 84% yield. Oxidation of 9 using pyridinium chlorochromate (PCC) followed by Wittig reaction using AcCH=PPh 3 afforded enone 7. This enone could be reduced to 1 using hydrogen gas with Pd/C catalyst in 70% overall yield from 9.
Pyrone 1 is prepared in five steps from pyrone 8. This represents the first synthesis of 1, a promising antileukemic natural product.
Experimental

4-Hydroxy-5-methoxycarbonyl-6-methyl-2-pyrone (8):
A solution of methyl acetoacetate (11.0 mL, 102 mmol) and malonyl chloride (9.92 mL, 102 mmol) in anhydrous CH 2 Cl 2 (300 mL) was stirred at r.t. for 7 days. After which, the mixture was then washed with aqueous sat. NaHCO 3 . The aqueous layer was acidified with 1% aqueous HCl and the crude product extracted with CH 2 Cl 2 (3 × 150 mL). The combined organic extracts were washed with brine and dried over anhydrous Na 2 SO 4 . Solvent was evaporated under reduced pressure and the resulting crude residue was subjected to silica gel column flash chromatography (50% EtOAc in hexanes) to give 8 (7.7 g, 41%). R f : 0.3 (50% EtOAc in hexanes). 1 Ku & Kraus dropwise at 0 °C. The mixture was allowed to warm up to r.t. and stirred for an additional 2 hours. Anhydrous MeOH was added and the resulting mixture was stirred for 1 hour before being concentrated under reduced pressure. The crude residue was used for the next step without further purification.
To a solution of the crude product above (910 mg, 5.83 mmol) in acetone (20 mL) was added anhydrous K 2 CO 3 (2.4 g, 17.37 mmol) and dimethyl sulfate (1.1 mL, 11.6 mmol). The mixture was refluxed overnight. The mixture was filtered through Celite and concentrated under reduced pressure. Recrystallization of the crude product from EtOAc-hexane gave 9 (992 mg, 84%). 1 -6-methyl-5-(3-oxobutyl)-2H-pyran-2-one (1): A solution of 7 (123.7 mg, 0.59 mmol) in ethanol under H 2 atmosphere (1 atm) was stirred overnight in the presence of 10 mol % Pd/C (10% wt.). After which, the catalyst was removed by Celite and the filtrate was evaporated under reduced pressure. The crude product was purified by preparative TLC (silica gel, EtOAc : hexanes 2:1) to afford 1 in 89% yield. 1 
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